What's truly scarce is the ability to judge when to use and when to refuse.

Let's start with Nora.
A woman who had recently immigrated to the United States, carrying the anxiety of sudden bleeding, a well-organized medical history in English, and a referral document marked "Urgent," walked into a clinic. Then, she was turned away.
Starting with her experience, we published six reports, touching upon the cracks in law enforcement, the control of medical records, the power logic of referrals, and the infiltration of capital and platforms into medical decision-making. We also heard the story of Dr. Chen Jiarui—a surgeon who, after becoming a patient, decided to question the system from its very foundation.
Now, it's time to answer a bigger question:
What exactly does healthcare sovereignty mean? What are its most real challenges today?

(Image caption) The starting point of healthcare sovereignty is not institutional documents, but whether a person can be truly supported by the system in their most vulnerable moments.

I. Three Levels of Healthcare Sovereignty In this series, healthcare sovereignty is presented in three distinct but interconnected levels.
Healthcare sovereignty at the individual level: the ability to be caught. Nora's story illustrates that, at the most concrete level, healthcare sovereignty means whether a person can be truly caught by the system in their most vulnerable moments—when they are sick, anxious, or in an unfamiliar institutional environment.
Being received means more than just physically entering the consultation room; it means being understood (language assistance), being informed (information transparency), being respected (participation in decision-making), and being able to correct errors when the system fails (appeal mechanism).
All four dimensions were missing during Nora's first visit, but appeared during her second. The same patient, in the same United States, on the same day, experienced completely different states of healthcare sovereignty due to the presence or absence of these four dimensions.
Individual-level healthcare sovereignty is not abstract; it exists in the specific details of each medical visit.
Healthcare sovereignty at the institutional level: the ability to redesign. Chen Jiarui's story illustrates that healthcare sovereignty at the institutional level means whether a society—or professionals within an institution—possesses the ability to redesign healthcare rules, rather than simply accepting the logic imposed on it by the existing system.
This capability is scarce. Most changes in healthcare systems occur under immense external pressure (financial crises, public health emergencies, technological disruptions), rather than stemming from proactive self-renewal within the system. Without sufficient external pressure, the inertia of the system is far stronger than the will to reform.
Chen Jiarui has chosen an unconventional path: starting from the clinical field and using his personal capital to bear the risks of institutional experimentation. The outcome of this choice remains to be seen. But the awareness it represents—that systems can be redesigned—is itself a declaration worthy of serious consideration.
Global Healthcare Sovereignty: The Ability to Set Allocation Rules. A global comparison of six reports illustrates that healthcare sovereignty at the global level means whether a country or community has the ability to participate in or even influence the setting of global healthcare rules—including drug pricing mechanisms, data sovereignty frameworks, AI ethical standards, and the international architecture of healthcare financing.
This level of healthcare sovereignty is highly unequally distributed across different political and economic sizes globally. A country capable of negotiating national-level pricing with pharmaceutical companies and a country that can only accept prices set by pharmaceutical companies occupy entirely different positions in the practical sense of healthcare sovereignty.

(Image caption) The way a system truly affects people is not through abstract principles, but through whether it provides a clear, accessible, and error-correctable medical pathway.

II. Today’s most real challenge: Technology accelerates the transfer of sovereignty. In this series of investigations, we have identified a dominant trend: technology is accelerating the restructuring of healthcare sovereignty, and in many cases, this restructuring does not point to the enhancement of patient sovereignty, but rather to new forms of centralization.
Insurance companies, through algorithm-optimized pre-authorization, can make more medical intervention decisions in a shorter time. Technology platforms, through convenient health management tools, accumulate vast amounts of medical data without patients' awareness. Pharmaceutical companies, through precise pricing algorithms, identify the upper limit of willingness to pay in different markets and maximize profit extraction.
These technological applications all have their own efficiency logic and commercial rationale. However, their common institutional effect is to shift the substantive control of medical decisions from the physician-patient relationship to technology platforms, insurance algorithms, and pharmaceutical pricing models.
What is disappearing during this transfer?
What has disappeared is judgment.
It's not a data-driven judgment, nor an algorithm-optimized judgment, but a judgment made after considering all the factors that cannot be quantified within a specific human context—a doctor looks at a patient, understands her fears, her family situation, her values, and then says, "In your case, I think this approach is more suitable for you."
This judgment is the core of medical sovereignty. It is a capability that technology can assist but cannot replace.

(Image caption) What is truly scarce is not more data, nor faster algorithms, but the ability to judge when to use and when to refuse in specific human situations.

III. What is needed to rewrite the underlying rules of healthcare? Chen Jiarui said: "Healthcare can be redesigned."
We agree with this direction. But as we've also seen in this series, rewriting requires more than just technical skill.
It requires a clear definition of the problem.
Nora's experience appears to be a case of personal service failure, but when placed within the legal framework, the obligation to provide language assistance, and the design of error correction mechanisms, it becomes a problem of institutional design. The clarity of the problem definition determines the effectiveness of the solution.
It requires the will to execute, not just institutional texts.
The obligation to assist with language needs has existed in the United States for sixty years. The problem is not that the rules don't exist, but that they are not being enforced in specific clinics and at specific times. The gap between the written rules and their implementation is the most common point of failure for healthcare sovereignty.
It needs an accountability mechanism to ensure that mistakes have consequences.
A system can function because mistakes have consequences. When a doctor refuses to assist a patient with a speech impairment, and this refusal has no formal repercussions, the system loses its self-correcting ability. Accountability is not about punishment, but about ensuring that the system's commitments are not empty words.
It requires patient empowerment, not just patient protection.
One of the most important differences lies in the design distinction between "protecting patients" and "empowering patients." Protection assumes patients are passive recipients, while empowerment assumes they are active participants. True healthcare sovereignty requires patients to understand their choices, exercise their rights, and initiate corrective measures when the system fails. This requires information, knowledge, and proactive investment in system design.

(Image caption) Rewriting the underlying rules of healthcare relies not only on technological tools, but also on the joint establishment of problem definition, execution will, accountability mechanisms, and patient empowerment.

IV. What will GFM continue to do? The first season of "Medical Sovereignty" completed a starting point with seven episodes.
From Nora's medical visit to the language assistance obligations of the US healthcare system, to the comparison of global medical record sovereignty, to the power dissection of referral mechanisms, to the industrial restructuring of insurance, AI, pharmaceutical companies, and platform-based healthcare, to Chen Jiarui's experiment in trying to re-examine the underlying issues of the system—this series establishes an analytical framework, but the issues it touches upon are far broader than what seven reports can cover.
The second season will expand its focus to the Global South: healthcare finance sovereignty, drug accessibility, local manufacturing capabilities, and the sovereignty challenges of AI in healthcare in resource-scarce environments. When an African country's healthcare AI system receives training data from the United States, when the pricing of essential medicines in a Latin American country is determined by multinational pharmaceutical companies, and when a Southeast Asian country's healthcare data is stored on foreign cloud platforms, the specific implications of healthcare sovereignty in these scenarios deserve systematic recording and analysis.
We will continue to observe the actual operation of AiTmed and the Irvine Medical Examination Center, using it as a verifiable institutional model and documenting its progress and challenges in a real-world environment.

(Image caption) A truly sovereign healthcare system should not allow being "caught" to depend on luck, but should make understanding, transparency, choice, and error correction the norm.

Fifth, let's return to Nora. We'll begin with Nora and end with Nora.
That 5:24 PM call back, that case number, that doctor who was willing to spend two hours explaining all the options—these were the things that ultimately helped Nora get through: the system's self-correction after it had almost failed.
But corrections should not rely on luck. The system should be designed so that catching someone becomes the norm, not the exception.
Nora concludes her article by quoting Psalm 34: “I sought the Lord, and he answered me and delivered me from all my fears.”
We cannot comment on the dimension of faith. But as a media outlet that focuses on institutions, we can say:
Beyond faith, institutions can also be a form of support.
When the system is designed well enough—when language assistance is proactively provided, when medical records can be accessed smoothly, when referral paths are clear, and when error correction mechanisms are available—a person can be caught even in their most vulnerable moments, without needing luck.
This is the most basic and core meaning of medical sovereignty.
Turning this promise into reality is a matter of institutional design, a matter of political will, and a matter in which everyone who works within the system, receives medical care within the system, and makes decisions within the system can participate.

The first season of *Healthcare Sovereignty* consists of seven articles, produced by the GFM editorial team. This series does not constitute any medical or legal advice. To contact the GFM *Healthcare Sovereignty* editorial team, please use official GFM channels. Season 2 is in development.